Effect of long and short half-life PDE5 inhibitors on HbA1c levels: a systematic review and meta-analysisResearch in context
Summary: Background: Phosphodiesterase 5 (PDE5) inhibitors, owing to their mechanism of action, have been gaining recognition as a potential case of drug repurposing and combination therapy for diabetes treatment. We aimed to examine the effect of long and short half-life PDE5 inhibitors have on Ha...
Saved in:
| Main Authors: | Joseph Kim, Rui Zhao, Lawrence Richard Kleinberg, Kitai Kim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | EClinicalMedicine |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S258953702400614X |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Membrane-Mediated Action of Phosphodiesterase 5 Inhibitors
by: Anna I. Malykhina, et al.
Published: (2025-04-01) -
Analysis of thalassemia genotypes and HbA2 test results in pregnant women in Shenzhen, China
by: Hou Qian, et al.
Published: (2025-03-01) -
Vascular remodeling in arteriovenous fistula treated with PDE5A inhibitors
by: Maheshika Somarathna, et al.
Published: (2025-05-01) -
Is HbA1c Predictive for Screening and Diagnosis of Gestational Diabetes Mellitus?
by: Neslihan Yerebasmaz, et al.
Published: (2014-08-01) -
Correlation between Insulin antibodyand HbA1c in Diabetes Mellitus
by: Joumana Sharad, et al.
Published: (2024-12-01)